Search

Anemia is a common consequence of cancerous disease. In lung cancer its prevalence is 37.6%, and its incidence after chemotherapy treatment is 80%. It is a prognostic factor for survival and may affect the efficacy and safety of chemotherapy and radiation therapy. Objective: To estimate the prevalence and incidence of anemia in patients with lung cancer. Methods: retrospective study including all patients treated for lung cancer who had at least one anemic episode during 3 years. Results: The analysis included 264 lung cancer patients with hemoglobin less than 80% of normal, anemia was found in 33.7% of patients before any treatment, and in 66.3% of those treated with chemotherapy. The median age was 62 years ( Conclusion: Both the prevalence and incidence of anemia in lung cancer should be taken into consideration because of the strong correlation between anemia and quality of life and the prognosis of patients with.

The aim of our study was to determine the frequency and reasons for emergency room visits of patients with lung cancer and the procedures and results of their treatment. Patients and methods: Retrospective study on all patients with lung cancer monitoring within the hospital of Bab El Oued pulmonology department from January 2008 to November 2014 and has submitted an acute symptoms requiring emergency consultation. Results: Among the 858 patients with lung cancer followed in the pulmonology department during this period, 718 had emergency consultation, primarily for poor general condition 37.7%, respiratory complaints 40.6%, pain 19%, convulsion 12% or severe infectious syndrome 2%. The reason for consultation was mainly due to toxicity of treatment in 35% of cases and tumor progression in 29.8% of cases. The main diagnoses were superior vena cava syndrome 5.4%, brain metastases 15.6%, spinal cord compression 5.9%, pleural and pericardial effusions 10.2%, infection severe 2%, respiratory distress 2.8%, thromboembolic disease 13.3%, grade 3/4 anemia 23.6%, grade 3-4 neutropenia 8%, thrombocytopenia grade 3-4 4%, hyponatremia 3.1% and hypocalcemia 0.8%. The main treatments given included a decompressive radiation therapy in 21.7% of patients, anticoagulants in 13.3% of cases, a blood transfusion in 23.6% of cases and corticosteroids 23.8%, antibiotics 13, 3%. In the short term, mortality was 3.4%. Conclusion: Lung cancer patients frequently consult the emergency department for complications related to cancer or its treatment this underlines the importance of early use of supportive care alongside the oncological treatment.

We report the singular association of mediastinal pseudo-tumoral tuberculosis [TB] with systemic lupus erythematosus [SLE]. D. I, 22 years old woman, is followed for a SLE since 2006 controlled by hydrochloroquine ‘HCQ’200mg twice/day and a thyroiditis of Hashimoto under levothyrox 125 mg/d. It does not relate to tuberculosis. She is hospitalized in pneumology for progressive dyspnea and chest pain. Objective clinical examination shows a conserved general condition, apyrexia T° to 37, BMI to 21.1 (without notion of loss of weight), heart beat 94 / min, respiratory rate at 24 cycle/min and blood pressure at 110/60 mmHg. The pleuropulmonary and cardiovascular examination were without abnormality and thus the remainder of the clinical examination. The image of the thoracic face fails with a right para-cardiac opacity erasing the right edge of the cortex and the CT concludes to a mediastinal tumoral process, filling the gutter vertebral and extending from T6 to T10, with tissue density presenting areas of necrosis within it. Bronchial fibroscopy finds a thickening of inter-lobar spurs and bronchial biopsies identifies a bronchial mucosa site of chronic inflammatory remodeling with presence of multi-nucleated giant cells suggesting a tuberculoid process. The parameters of the hemogram were normal and the inflammatory syndrome was attested by both the increase ERS at 54 mm and the level of CRP at 12 mg/l. The smears, negative on direct examination, will prove positive for culture on Lowenstein medium. Antituberculosis treatment has been prescribed with good clinical, bacteriological and radiological progress. Long-term asymptomatic mediastinal pseudo-tumoral tuberculosis can be revealed at the compressive stage by dyspnea and chest pain. The fear of lymphoma requires biopsies with pathological examinations which sometimes reveal benign affections (tuberculosis, sarcoidosis in their tumor forms) which can enamel the autoimmune disorders characterizing a SLE.